Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Advisor to its Board and Chair of its R and D Committee
Read Article
News
2024
2023
Archive
Search news articles
May 18, 2020
IDEAYA Biosciences Announces AACR Abstracts for IDE196 Targeting GNAQ/11 Tumors and Preclinical MAT2A Synthetic Lethality Program
May 15, 2020
Aprea Therapeutics Reports First Quarter 2020 Financial Results and Provides Update on Business Operations
May 14, 2020
Arvinas Announces Updated Phase 1 Data Demonstrating Clinical Activity of PROTAC® Protein Degrader ARV-110 in Patients with Refractory Prostate Cancer
May 8, 2020
Entos and Precision NanoSystems Partner to Enable GMP Manufacturing of DNA COVID-19 Vaccine
May 6, 2020
Pear Therapeutics Launches Pear Assistance Program to Ensure Access to Prescription Digital Therapeutics, reSET® and reSET-O®, for People Living with Addiction
May 6, 2020
Cabaletta Bio Receives FDA Fast Track Designation for DSG3-CAART for the Treatment of Mucosal Pemphigus Vulgaris
May 6, 2020
Cidara Therapeutics Announces New Clinical and Preclinical Data for Rezafungin and Influenza AVCS from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
May 6, 2020
Impel NeuroPharma Announces Leadership Transition, Chairman Adrian Adams’ Role Expanded to Chairman and CEO
May 6, 2020
Rachael Alford, PhD Joins RallyBio to Lead CMC Operations
April 30, 2020
Pear Therapeutics to Release Pear-004 to Help People Living with Schizophrenia During the COVID-19 Crisis
« Previous Page
1
…
41
42
43
44
45
…
103